Chickasaw Capital Management’s Core Laboratories CLB Stock Holding History

Chickasaw Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-3,000	Closed	-$296K	–	107
2017 Q3	$296K	Hold	3,000	–	–	0.01%	89
2017 Q2	$304K	Hold	3,000	–	–	0.01%	86
2017 Q1	$347K	Hold	3,000	–	–	0.01%	84
2016 Q4	$360K	Hold	3,000	–	–	0.01%	76
2016 Q3	$337K	Hold	3,000	–	–	0.01%	73
2016 Q2	$372K	Hold	3,000	–	–	0.01%	77
2016 Q1	$337K	Hold	3,000	–	–	0.01%	77
2015 Q4	$326K	Hold	3,000	–	–	0.01%	79
2015 Q3	$299K	Hold	3,000	–	–	0.01%	82
2015 Q2	$342K	Hold	3,000	–	–	0.01%	81
2015 Q1	$313K	Buy	3,000 +1,000	+50%	+$107K	0.01%	85
2014 Q4	$241K	Buy	+2,000	New	+$263K	0.01%	92

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Chickasaw Capital Management's CLB Position: Q4 2017 in Review

Chickasaw Capital Management sold out of Core Laboratories (CLB) in Q4 2017, closing a stake of 3,000 shares — an estimated $296K sold.

Chickasaw Capital Management first reported a position in CLB in Q4 2014 and held it in 12 quarters. The position peaked at $372K in Q2 2016. 356 funds tracked by Wall St. Rank hold CLB as of Q4 2017.

Chickasaw Capital Management reported no remaining Core Laboratories position as of Q4 2017 after selling out during the quarter.
Chickasaw Capital Management sold 3,000 Core Laboratories shares in Q4 2017, an estimated $296K.
Chickasaw Capital Management first reported a position in Core Laboratories in Q4 2014 and held it in 12 quarters.
Chickasaw Capital Management's Core Laboratories position peaked at $372K in Q2 2016.
356 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2017.

Based on Chickasaw Capital Management's 13F filing for Q4 2017, filed 8 Jan 2018.